Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1. Ni, X., Heidenreich, D., Christott, T., Bennett, J., Moustakim, M., Brennan, P., Fedorov, O., Knapp, S., & Chaikuad, A. ACS Medicinal Chemistry Letters, 2019. doi abstract bibtex Copyright © 2019 American Chemical Society. YEATS-domain-containing MLLT1 is an acetyl/acyl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.
@article{
title = {Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1},
type = {article},
year = {2019},
keywords = {MLLT1,YEATS domains,cancer,inhibitor development,piperazine-urea},
volume = {10},
id = {28f185f1-d0b9-311c-b5d2-5700a7cd12aa},
created = {2019-12-19T23:59:00.000Z},
file_attached = {false},
profile_id = {64f7fb50-d000-335d-a02d-06c5f340a97a},
last_modified = {2021-02-27T01:23:11.400Z},
read = {false},
starred = {false},
authored = {true},
confirmed = {false},
hidden = {false},
private_publication = {true},
abstract = {Copyright © 2019 American Chemical Society. YEATS-domain-containing MLLT1 is an acetyl/acyl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.},
bibtype = {article},
author = {Ni, X. and Heidenreich, D. and Christott, T. and Bennett, J. and Moustakim, M. and Brennan, P.E. and Fedorov, O. and Knapp, S. and Chaikuad, A.},
doi = {10.1021/acsmedchemlett.9b00460},
journal = {ACS Medicinal Chemistry Letters},
number = {12}
}
Downloads: 0
{"_id":"igGrr6nrxtRvaABrk","bibbaseid":"ni-heidenreich-christott-bennett-moustakim-brennan-fedorov-knapp-etal-structuralinsightsintointeractionmechanismsofalternativepiperazineureayeatsdomainbindersinmllt1-2019","authorIDs":["g4JkphGbeNea298iY"],"author_short":["Ni, X.","Heidenreich, D.","Christott, T.","Bennett, J.","Moustakim, M.","Brennan, P.","Fedorov, O.","Knapp, S.","Chaikuad, A."],"bibdata":{"title":"Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1","type":"article","year":"2019","keywords":"MLLT1,YEATS domains,cancer,inhibitor development,piperazine-urea","volume":"10","id":"28f185f1-d0b9-311c-b5d2-5700a7cd12aa","created":"2019-12-19T23:59:00.000Z","file_attached":false,"profile_id":"64f7fb50-d000-335d-a02d-06c5f340a97a","last_modified":"2021-02-27T01:23:11.400Z","read":false,"starred":false,"authored":"true","confirmed":false,"hidden":false,"private_publication":"true","abstract":"Copyright © 2019 American Chemical Society. YEATS-domain-containing MLLT1 is an acetyl/acyl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.","bibtype":"article","author":"Ni, X. and Heidenreich, D. and Christott, T. and Bennett, J. and Moustakim, M. and Brennan, P.E. and Fedorov, O. and Knapp, S. and Chaikuad, A.","doi":"10.1021/acsmedchemlett.9b00460","journal":"ACS Medicinal Chemistry Letters","number":"12","bibtex":"@article{\n title = {Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1},\n type = {article},\n year = {2019},\n keywords = {MLLT1,YEATS domains,cancer,inhibitor development,piperazine-urea},\n volume = {10},\n id = {28f185f1-d0b9-311c-b5d2-5700a7cd12aa},\n created = {2019-12-19T23:59:00.000Z},\n file_attached = {false},\n profile_id = {64f7fb50-d000-335d-a02d-06c5f340a97a},\n last_modified = {2021-02-27T01:23:11.400Z},\n read = {false},\n starred = {false},\n authored = {true},\n confirmed = {false},\n hidden = {false},\n private_publication = {true},\n abstract = {Copyright © 2019 American Chemical Society. YEATS-domain-containing MLLT1 is an acetyl/acyl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.},\n bibtype = {article},\n author = {Ni, X. and Heidenreich, D. and Christott, T. and Bennett, J. and Moustakim, M. and Brennan, P.E. and Fedorov, O. and Knapp, S. and Chaikuad, A.},\n doi = {10.1021/acsmedchemlett.9b00460},\n journal = {ACS Medicinal Chemistry Letters},\n number = {12}\n}","author_short":["Ni, X.","Heidenreich, D.","Christott, T.","Bennett, J.","Moustakim, M.","Brennan, P.","Fedorov, O.","Knapp, S.","Chaikuad, A."],"biburl":"https://bibbase.org/service/mendeley/64f7fb50-d000-335d-a02d-06c5f340a97a","bibbaseid":"ni-heidenreich-christott-bennett-moustakim-brennan-fedorov-knapp-etal-structuralinsightsintointeractionmechanismsofalternativepiperazineureayeatsdomainbindersinmllt1-2019","role":"author","urls":{},"keyword":["MLLT1","YEATS domains","cancer","inhibitor development","piperazine-urea"],"metadata":{"authorlinks":{"brennan, p":"https://www.brennanresearchgroup.com/publications"}},"downloads":0},"bibtype":"article","creationDate":"2021-02-28T06:25:23.872Z","downloads":0,"keywords":["mllt1","yeats domains","cancer","inhibitor development","piperazine-urea"],"search_terms":["structural","insights","interaction","mechanisms","alternative","piperazine","urea","yeats","domain","binders","mllt1","ni","heidenreich","christott","bennett","moustakim","brennan","fedorov","knapp","chaikuad"],"title":"Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1","year":2019,"biburl":"https://bibbase.org/service/mendeley/64f7fb50-d000-335d-a02d-06c5f340a97a","dataSources":["Pa586au6MYhHM9r97","ya2CyA73rpZseyrZ8","2252seNhipfTmjEBQ"]}